Management of Borderline Resectable Pancreatic Cancer

被引:49
|
作者
Katz, Matthew H. G. [1 ]
Crane, Christopher H. [2 ]
Varadhachary, Gauri [3 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Dept Radiat Oncol, Houston, TX 77030 USA
[3] Univ Texas MD Anderson Canc Ctr, Dept Med Oncol, Houston, TX 77030 USA
关键词
GEMCITABINE-BASED CHEMORADIATION; EXPERT CONSENSUS STATEMENT; PREOPERATIVE GEMCITABINE; RADIATION-THERAPY; MULTIINSTITUTIONAL PHASE-2; NEOADJUVANT GEMCITABINE; CONTROLLED-TRIAL; DOSE-ESCALATION; ADENOCARCINOMA; CHEMOTHERAPY;
D O I
10.1016/j.semradonc.2013.11.006
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Borderline resectable pancreatic cancers are those that, although technically resectable, are at high risk for margin-positive resection following surgery de novo. Generally, such cancers are characterized by localized primary tumors that involve the mesenteric vasculature to a limited degree and that may require venous or hepatic arterial resection at pancreatectomy. In this article, we review diagnosis and staging algorithms, pretreatment strategies, and multidisciplinary treatment protocols for patients with this stage of disease. The rationale for and results following treatment with neoadjuvant chemotherapy and chemoradiation and subsequent surgical resection of the primary tumor are described in detail and existing data are reviewed. (C) 2014 Elsevier Inc. All rights reserved.
引用
收藏
页码:105 / 112
页数:8
相关论文
共 50 条
  • [1] Management of Borderline Resectable Pancreatic Cancer
    Lal, Alysandra
    Christians, Kathleen
    Evans, Douglas B.
    SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA, 2010, 19 (02) : 359 - +
  • [2] Management of borderline resectable pancreatic cancer
    Amit Mahipal
    Jessica Frakes
    Sarah Hoffe
    Richard Kim
    World Journal of Gastrointestinal Oncology, 2015, (10) : 241 - 249
  • [3] Management of borderline resectable pancreatic cancer
    Mahipal, Amit
    Frakes, Jessica
    Hoffe, Sarah
    Kim, Richard
    WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2015, 7 (10) : 241 - 249
  • [4] Management of Borderline Resectable Pancreatic Cancer
    Toesca, Diego A. S.
    Koong, Amanda J.
    Poultsides, George A.
    Visser, Brendan C.
    Haraldsdottir, Sigurdis
    Koong, Albert C.
    Chang, Daniel T.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 100 (05): : 1155 - 1174
  • [5] Borderline resectable pancreatic cancer: Definitions and management
    Nicole E Lopez
    Cristina Prendergast
    Andrew M Lowy
    World Journal of Gastroenterology, 2014, (31) : 10740 - 10751
  • [6] Borderline resectable pancreatic cancer: Definitions and management
    Lopez, Nicole E.
    Prendergast, Cristina
    Lowy, Andrew M.
    WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (31) : 10740 - 10751
  • [7] Management of a Patient With Borderline Resectable Pancreatic Cancer
    Shah, Anand P.
    Strauss, Jonathan B.
    Leslie, William T.
    Shah, Amar
    Mahon, Brett
    Abrams, Ross A.
    ONCOLOGY-NEW YORK, 2008, 22 (13): : 1524 - 1529
  • [8] Definition and Management of Borderline Resectable Pancreatic Cancer
    Denbo, Jason W.
    Fleming, Jason B.
    SURGICAL CLINICS OF NORTH AMERICA, 2016, 96 (06) : 1337 - +
  • [9] Borderline resectable pancreatic cancer
    Hackert, Thilo
    Ulrich, Alexis
    Buechler, Markus W.
    CANCER LETTERS, 2016, 375 (02) : 231 - 237
  • [10] Borderline resectable pancreatic cancer
    Varadhachary G.R.
    Tamm E.P.
    Crane C.
    Evans D.B.
    Wolff R.A.
    Current Treatment Options in Gastroenterology, 2005, 8 (5) : 377 - 384